Home
BVS
BVS News

Latest Bioventus Inc. (BVS) News on February 23, 2025

Recursion Pharmaceuticals (RXRX) Stock Jumps 8.9%: Will It Continue to Soar?

Zacks

10 days ago

Recursion Pharmaceuticals (RXRX) Stock Jumps 8.9%: Will It Continue to Soar?

With 32% ownership, Bioventus Inc. (NASDAQ:BVS) has piqued the interest of institutional investors

Simply Wall St.

23 days ago

With 32% ownership, Bioventus Inc. (NASDAQ:BVS) has piqued the interest of institutional investors

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 months ago

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business

Zacks

2 months ago

BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business

Bioventus completes divestiture of its Advanced Rehabilitation business

TipRanks

2 months ago

Bioventus completes divestiture of its Advanced Rehabilitation business

MT Newswires

2 months ago

Bioventus Sells Advanced Rehabilitation Business to Accelmed Partners

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

GlobeNewswire

2 months ago

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?

Zacks

2 months ago

Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?

MT Newswires

2 months ago

JPMorgan Upgrades Bioventus to Neutral From Underweight, Adjusts Price Target to $13 From $12

Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet

Zacks

3 months ago

Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet

Thomson Reuters StreetEvents

4 months ago

Q3 2024 Bioventus Inc Earnings Call

Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

GuruFocus.com

4 months ago

Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

MT Newswires

4 months ago

Bioventus' Shares Down in Early Trading Amid Higher Q3 Results

Bioventus (BVS) Matches Q3 Earnings Estimates

Zacks

4 months ago

Bioventus (BVS) Matches Q3 Earnings Estimates

Associated Press Finance

4 months ago

Bioventus: Q3 Earnings Snapshot

Bioventus Reports Third Quarter Financial Results

GlobeNewswire

4 months ago

Bioventus Reports Third Quarter Financial Results

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For

GuruFocus.com

4 months ago

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For

Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?

Zacks

4 months ago

Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

GlobeNewswire

4 months ago

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

MT Newswires

4 months ago

Bioventus Files $200 Million Mixed-Shelf Offering

Bioventus Surges 73% in Three Months: Time to Buy the Stock?

Zacks

4 months ago

Bioventus Surges 73% in Three Months: Time to Buy the Stock?

Are Medical Stocks Lagging ChromaDex (CDXC) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging ChromaDex (CDXC) This Year?

Solventum Stock Earns 81 RS Rating

Investor's Business Daily

4 months ago

Solventum Stock Earns 81 RS Rating

Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

4 months ago

Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

MT Newswires

5 months ago

Bioventus to Sell Advanced Rehabilitation Business to Accelmed Partners

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

GlobeNewswire

5 months ago

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal

Zacks

5 months ago

ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal

Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market

Zacks

5 months ago

Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

Zacks

5 months ago

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

Zacks

5 months ago

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

Zacks

5 months ago

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

Longboard Stock Soars on FDA Designations for Epilepsy Drug

Zacks

5 months ago

Longboard Stock Soars on FDA Designations for Epilepsy Drug

GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines

Zacks

5 months ago

GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines

Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?

Zacks

5 months ago

Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?

Ascendis Soars on Encouraging Data From Dwarfism Drug Study

Zacks

5 months ago

Ascendis Soars on Encouraging Data From Dwarfism Drug Study

Xencor Stock Gains 23% on Encouraging Pipeline Advancements

Zacks

5 months ago

Xencor Stock Gains 23% on Encouraging Pipeline Advancements

Summit Hits Record High on Lung Cancer Drug Topping Merck's Keytruda

Zacks

5 months ago

Summit Hits Record High on Lung Cancer Drug Topping Merck's Keytruda

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years

Zacks

6 months ago

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years

JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab

Zacks

6 months ago

JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab

Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data

Zacks

6 months ago

Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data

Bull Of The Day: Bioventus (BVS)

Zacks

6 months ago

Bull Of The Day: Bioventus (BVS)

Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day

Zacks

6 months ago

Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day

Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs

Zacks

6 months ago

Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs

Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review

Zacks

6 months ago

Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review

Insmed Stock Surges 168% in the Past Six Months: Here's Why

Zacks

6 months ago

Insmed Stock Surges 168% in the Past Six Months: Here's Why

AstraZeneca (AZN) Denies Rumors About UK Facility Relocation

Zacks

6 months ago

AstraZeneca (AZN) Denies Rumors About UK Facility Relocation

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

Zacks

6 months ago

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia

Zacks

6 months ago

Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia

5 Small Drug Stocks to Buy as Innovation Reaches Peak

Zacks

6 months ago

5 Small Drug Stocks to Buy as Innovation Reaches Peak

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

GlobeNewswire

6 months ago

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

Bioventus Reports Second Quarter Financial Results

GlobeNewswire

7 months ago

Bioventus Reports Second Quarter Financial Results

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

GlobeNewswire

7 months ago

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner

Zacks

8 months ago

Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

8 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

8 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

8 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

8 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

8 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

8 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

8 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

8 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

8 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

8 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

8 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

8 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

8 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

8 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

8 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

8 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Here's Why You Should Consider Buying Bioventus (BVS) Stock

Zacks

9 months ago

Here's Why You Should Consider Buying Bioventus (BVS) Stock

J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe

Zacks

9 months ago

J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

Zacks

9 months ago

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

Merck (MRK) to Buy Private Ophthalmology Company EyeBio

Zacks

9 months ago

Merck (MRK) to Buy Private Ophthalmology Company EyeBio

J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate

Zacks

9 months ago

J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate

Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript

GuruFocus.com

9 months ago

Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ...

Thomson Reuters StreetEvents

9 months ago

Q1 2024 Bioventus Inc Earnings Call

Bioventus Reports First Quarter Financial Results

GlobeNewswire

10 months ago

Bioventus Reports First Quarter Financial Results

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

GlobeNewswire

10 months ago

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 Bioventus Inc Earnings Call

Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ...

GuruFocus.com

a year ago

Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ...

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

GlobeNewswire

a year ago

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

OneWater Marine Inc. Reports Mixed Fiscal Q1 2024 Results Amidst Market Challenges

GuruFocus.com

a year ago

OneWater Marine Inc. Reports Mixed Fiscal Q1 2024 Results Amidst Market Challenges

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Abercrombie & Fitch, Cameco, CyberArk Software and LendingTree

Zacks

a year ago

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Abercrombie & Fitch, Cameco, CyberArk Software and LendingTree

OneWater Marine (ONEW) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

a year ago

OneWater Marine (ONEW) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Banc of California (BANC) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a year ago

Banc of California (BANC) Reports Q4 Loss, Tops Revenue Estimates

Business Wire

a year ago

nLIGHT to Announce Fourth Quarter 2023 Financial Results on February 22nd

Time is Running Out to Close the Widening Skills Gap, Reveals New Research from TrueBlue's PeopleScout in Partnership with Spotted Zebra

PR Newswire

a year ago

Time is Running Out to Close the Widening Skills Gap, Reveals New Research from TrueBlue's PeopleScout in Partnership with Spotted Zebra

8x8, Inc. Schedules Third Quarter Fiscal 2024 Earnings Release and Conference Call

Business Wire

a year ago

8x8, Inc. Schedules Third Quarter Fiscal 2024 Earnings Release and Conference Call

Ceva, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

PR Newswire

a year ago

Ceva, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

W&T Offshore Announces Closing of Accretive Acquisition of Six Gulf of Mexico Fields

GlobeNewswire

a year ago

W&T Offshore Announces Closing of Accretive Acquisition of Six Gulf of Mexico Fields

Shareholders Would Enjoy A Repeat Of Hackett Group's (NASDAQ:HCKT) Recent Growth In Returns

Simply Wall St.

a year ago

Shareholders Would Enjoy A Repeat Of Hackett Group's (NASDAQ:HCKT) Recent Growth In Returns

Oil-Dri Corporation of America's (NYSE:ODC) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.

a year ago

Oil-Dri Corporation of America's (NYSE:ODC) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

GlobeNewswire

a year ago

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

Jewelry Looking Grimy? Here’s How to Clean It at Home

The Wall Street Journal

a year ago

Jewelry Looking Grimy? Here’s How to Clean It at Home

8x8 Extends XCaaS Platform AI Capabilities with Real-time Meeting Transcriptions and Smart Summarizations

Business Wire

a year ago

8x8 Extends XCaaS Platform AI Capabilities with Real-time Meeting Transcriptions and Smart Summarizations

Calculating The Fair Value Of nLIGHT, Inc. (NASDAQ:LASR)

Simply Wall St.

a year ago

Calculating The Fair Value Of nLIGHT, Inc. (NASDAQ:LASR)

Share on Social Networks: